Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non‐small cell lung cancer

This study was conducted to investigate the relationship between genetic variants in LKB1/AMPK/mTOR pathway and treatment outcomes of patients with non‐small cell lung cancer (NSCLC) treated with chemotherapy. A total of 379 patients with NSCLC who underwent first‐line paclitaxel‐cisplatin chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sun Ha, Do, Sook Kyung, Lee, Shin Yup, Choi, Jin Eun, Kang, Hyo‐Gyoung, Hong, Mi Jeong, Lee, Jang Hyuck, Lee, Won Kee, Jeong, Ji Yun, Shin, Kyung Min, Do, Young Woo, Lee, Eung Bae, Park, Ji Eun, Lee, Yong Hoon, Seo, Hyewon, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715851/
https://www.ncbi.nlm.nih.gov/pubmed/36239337
http://dx.doi.org/10.1111/1759-7714.14688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715851/
https://www.ncbi.nlm.nih.gov/pubmed/36239337
http://dx.doi.org/10.1111/1759-7714.14688

Ejemplares similares